Fiera Capital Corp Arrowhead Pharmaceuticals, Inc. Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 22, 2024	SELL	$21.2 - $31.03 $21,666 - $31,712	-1,022 Reduced 1.73%	58,036 $1.78 Million
Q4 2023 Feb 08, 2024	SELL	$21.2 - $31.03 $21,666 - $31,712	-1,022 Reduced 1.73%	58,036 $1.78 Million
Q3 2023 Aug 22, 2024	BUY	$26.2 - $36.08 $1.55 Million - $2.13 Million	59,058 New	59,058 $1.59 Million
Q2 2023 Aug 09, 2023	BUY	$25.16 - $41.38 $754 - $1,241	30 Added 0.05%	59,058 $2.11 Million
Q1 2023 Apr 26, 2023	SELL	$23.68 - $38.51 $24.3 Million - $39.5 Million	-1,024,627 Reduced 94.55%	59,028 $1.5 Million
Q4 2022 Feb 08, 2023	SELL	$28.0 - $40.56 $309,036 - $447,660	-11,037 Reduced 1.01%	1,083,655 $44 Million
Q3 2022 Nov 03, 2022	SELL	$29.63 - $48.31 $722,112 - $1.18 Million	-24,371 Reduced 2.18%	1,094,692 $33.2 Million
Q2 2022 Aug 10, 2022	SELL	$27.79 - $50.61 $517,588 - $942,611	-18,625 Reduced 1.64%	1,119,063 $39.4 Million
Q1 2022 May 09, 2022	SELL	$39.62 - $69.97 $597,509 - $1.06 Million	-15,081 Reduced 1.31%	1,137,688 $52.3 Million
Q4 2021 Feb 08, 2022	SELL	$58.09 - $82.51 $2.56 Million - $3.64 Million	-44,122 Reduced 3.69%	1,152,769 $76.4 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $1.06 Million - $1.54 Million	-18,073 Reduced 1.49%	1,196,891 $74.7 Million
Q2 2021 Aug 11, 2021	SELL	$62.15 - $90.32 $2.04 Million - $2.97 Million	-32,850 Reduced 2.63%	1,214,964 $52.5 Million
Q1 2021 May 11, 2021	SELL	$61.35 - $90.47 $1.69 Million - $2.49 Million	-27,525 Reduced 2.16%	1,247,814 $82.7 Million
Q4 2020 Feb 09, 2021	BUY	$43.82 - $85.37 $1.19 Million - $2.32 Million	27,199 Added 2.18%	1,275,339 $97.9 Million
Q3 2020 Nov 12, 2020	SELL	$33.21 - $51.27 $1.39 Million - $2.14 Million	-41,762 Reduced 3.24%	1,248,140 $53.7 Million
Q2 2020 Aug 07, 2020	SELL	$26.12 - $43.27 $1.09 Million - $1.8 Million	-41,625 Reduced 3.13%	1,289,902 $55.7 Million
Q1 2020 May 08, 2020	SELL	$20.56 - $63.12 $697,374 - $2.14 Million	-33,919 Reduced 2.48%	1,331,527 $38.3 Million
Q4 2019 Feb 06, 2020	SELL	$28.14 - $73.01 $2.93 Million - $7.61 Million	-104,250 Reduced 7.09%	1,365,446 $86.6 Million
Q3 2019 Nov 12, 2019	SELL	$26.26 - $34.86 $842,762 - $1.12 Million	-32,093 Reduced 2.14%	1,469,696 $41.4 Million
Q2 2019 Aug 12, 2019	SELL	$17.43 - $28.82 $931,912 - $1.54 Million	-53,466 Reduced 3.44%	1,501,789 $39.8 Million
Q1 2019 May 10, 2019	SELL	$12.05 - $20.18 $271,317 - $454,372	-22,516 Reduced 1.43%	1,555,255 $28.5 Million
Q4 2018 Feb 12, 2019	BUY	$10.74 - $19.7 $16.9 Million - $31.1 Million	1,577,771 New	1,577,771 $19.6 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account